Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124030452 | 12403045 | 2 | F | 20160421 | 20160819 | 20160525 | 20160823 | EXP | AU-ROCHE-1761688 | ROCHE | 32.58 | YR | F | Y | 0.00000 | 20160823 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124030452 | 12403045 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 400 | MG | SOLUTION FOR INFUSION | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124030452 | 12403045 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124030452 | 12403045 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124030452 | 12403045 | Abdominal pain upper | |
| 124030452 | 12403045 | Arthralgia | |
| 124030452 | 12403045 | Chest pain | |
| 124030452 | 12403045 | Dyspnoea | |
| 124030452 | 12403045 | Joint swelling | |
| 124030452 | 12403045 | Melaena | |
| 124030452 | 12403045 | Pruritus generalised | |
| 124030452 | 12403045 | Rash | |
| 124030452 | 12403045 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124030452 | 12403045 | 1 | 20160421 | 20160519 | 0 |